http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103301146-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140efb7e2a330be53d94bda6ad75cbe5 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate | 2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f5e9b42e8c6d55d0f862e07c966542c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e7b3fee6e0e03dc2b067e060cfcfdd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb02b78fc50a037f28d185aaa7e8835e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c09711865bfc1024b0deb6033e2a73 |
publicationDate | 2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103301146-B |
titleOfInvention | Traditional Chinese medicine monomer combination capable of resisting oxidation and improving eyeground blood circulation |
abstract | The invention relates to a traditional Chinese medicine monomer combination capable of resisting oxidation and improving eyeground blood circulation. The traditional Chinese medicine monomer combination comprises the following components in parts by weight: 1.5 to 6.0 parts of ligustrazine, 0.5 to 1.5 parts of catalpol, 1.5 to 6.0 parts of ferulic acid, and 3.0 to 15 parts of paeoniflorin. According to the traditional Chinese medicine monomer combination, the conventional processing method is adopted and used for preparing injection, oral liquid, capsules, troches and preparations of other forms based on the traditional Chinese medicine monomer. The traditional Chinese medicine monomer combination is mainly used for resisting oxidization and protecting free radicals, can prevent and delay the deformation and development of cataract and improve the eyeground blood circulation, also can treat uvea and retina vascular diseases and eye malnutritional lesion, nourish optic nerve and recover visual functions from glaucoma, traumatic optic nerve diseases and visual pathway diseases. |
priorityDate | 2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 443.